110 related articles for article (PubMed ID: 24651383)
1. Regulators of prostate cancer stem cells.
Kerr CL; Hussain A
Curr Opin Oncol; 2014 May; 26(3):328-33. PubMed ID: 24651383
[TBL] [Abstract][Full Text] [Related]
2. [Cancer stem cells in prostate cancer].
Nishida S; Masumori N
Nihon Rinsho; 2014 Dec; 72(12):2229-33. PubMed ID: 25518363
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of embryonic and induced pluripotent stem cells.
Guenther MG
Epigenomics; 2011 Jun; 3(3):323-43. PubMed ID: 22122341
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of pluripotency.
Chen L; Daley GQ
Hum Mol Genet; 2008 Apr; 17(R1):R23-7. PubMed ID: 18632692
[TBL] [Abstract][Full Text] [Related]
5. Roles of microRNAs during prostatic tumorigenesis and tumor progression.
Fang YX; Gao WQ
Oncogene; 2014 Jan; 33(2):135-47. PubMed ID: 23455326
[TBL] [Abstract][Full Text] [Related]
6. [The alchemy--epigenetic regulation of pluripotency].
Bem J; Grabowska I
Postepy Biochem; 2013; 59(2):144-56. PubMed ID: 24044279
[TBL] [Abstract][Full Text] [Related]
7. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
Miki J; Rhim JS
Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent human stem cell lines: what we can learn about cancer initiation.
Werbowetski-Ogilvie TE; Bhatia M
Trends Mol Med; 2008 Aug; 14(8):323-32. PubMed ID: 18635398
[TBL] [Abstract][Full Text] [Related]
9. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of cancer stem cells in human prostate cancer cells.
Lee EK; Cho H; Kim CW
Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms that mediate stem cell self-renewal and differentiation.
Zhang H; Wang ZZ
J Cell Biochem; 2008 Feb; 103(3):709-18. PubMed ID: 17647265
[TBL] [Abstract][Full Text] [Related]
12. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
13. Embryonic stem cell markers expression in cancers.
Schoenhals M; Kassambara A; De Vos J; Hose D; Moreaux J; Klein B
Biochem Biophys Res Commun; 2009 May; 383(2):157-62. PubMed ID: 19268426
[TBL] [Abstract][Full Text] [Related]
14. The roles of LSD1-mediated epigenetic modifications in maintaining the pluripotency of bladder cancer stem cells.
Lan W; Zhang D; Jiang J
Med Hypotheses; 2013 Nov; 81(5):823-5. PubMed ID: 24064254
[TBL] [Abstract][Full Text] [Related]
15. A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells.
Postovit LM; Seftor EA; Seftor RE; Hendrix MJ
Stem Cells; 2006 Mar; 24(3):501-5. PubMed ID: 16293574
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases.
Colombel M; Eaton CL; Hamdy F; Ricci E; van der Pluijm G; Cecchini M; Mege-Lechevallier F; Clezardin P; Thalmann G
Prostate; 2012 May; 72(7):713-20. PubMed ID: 21882211
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
18. [Cancer stem cells in solid tumors].
Hirose H; Yamamoto H; Miyoshi N; Uemura M; Miyazaki S; Takahashi H; Takemasa I; Mizushima T; Ikeda M; Ishii H; Sekimoto M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2809-12. PubMed ID: 21160254
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
20. Differences between human embryonic stem cell lines.
Allegrucci C; Young LE
Hum Reprod Update; 2007; 13(2):103-20. PubMed ID: 16936306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
